Humans have used psychedelic mushrooms for decades for different purposes, like traditional healing rituals and recreation. Despite the massive usage of psychedelic mushrooms over the years, we didn’t realize the therapeutic effects of magic mushrooms until recently. Yes, studies have found that psychedelic mushrooms can serve as a therapeutic substance in the treatment of some health issues.
New research has uncovered significant benefits of psilocybin, a key ingredient in magic mushrooms. This compound has promoted remarkable improvements for people dealing with addiction and depression, as well as post-traumatic stress disorder. Which brings the question, could psychedelic mushrooms shape the future of medicine? Let us see how psilocybin retreat can be used to offer relief for people dealing with depression, addiction, and post-traumatic stress disorder.
How Psychedelic Mushrooms are Shaping the Future of Medicine
To prove the therapeutic effects of psychedelic mushrooms on health issues like addiction, depression, and PTSD, we have compiled several studies below.
Addiction
There is a credible study that proves the significance of psilocybin (psychedelic compound in magic mushrooms) in treating opioid addiction. According to the study, a patient can enjoy great benefits from one session of psilocybin-assisted therapy. The study found that past use of psilocybin significantly corresponded with lower chances of opioid use disorder based on seven of eleven criteria used by scientists to diagnose the problem.
According to “Scientific Reports,” the 2022 study (conducted on April 7) determined a connection between prior use of psilocybin and a reduced occurrence of opioid addiction. Researchers did their study on 214,505 individuals living in the United States from the NSDUH (the National Survey on Drug Use and Health) over four years (2015 to 2019).
Depression
There are promising reports regarding using psilocybin to tackle depression based on several studies. However, we will only mention one of these studies here. During the Johns Hopkins Medicine study, researchers found that psilocybin relieved the symptoms of depression in adults for one month. The study showed how psilocybin rapidly improves the mood of patients.
Psilocybin had a persistent and rapid clinical effect in the patients, primarily when used for treating drug-resistant depression or depression caused by end-of-life illnesses. Psilocybin is well tolerated, and its side effects are limited. The compound treats depression by giving your brain the chance to adapt to any challenging experiences you might be facing.
PTSD
Researchers have proven that psilocybin has a positive effect when used to treat PTSD. According to one study, psilocybin treats PTSD by encouraging emotional release and processing, which allows the person to confront their trauma and overcome it.In one study that proved the therapeutic effects of psychedelic mushrooms on PTSD, the symptoms of 80 percent of the participants improved significantly after two sessions of psilocybin-assisted therapy. The study was done by MAPs (the Multidisciplinary Association for Psychedelic Studies).
Conclusion
Although more research is needed to prove the medicinal effects of psychedelic compounds, the studies above have proven that magic mushrooms could revolutionize the future of mental health medicine. The major compound, psilocybin, has helped us overcome any drawbacks of using conventional treatments for PTSD, depression, and addiction.
